Articular Cartilage Tissue Engineering (Record no. 85193)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 03864nam a22005535i 4500 |
001 - CONTROL NUMBER | |
control field | 978-3-031-02578-5 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240730164005.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 220601s2010 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9783031025785 |
-- | 978-3-031-02578-5 |
082 04 - CLASSIFICATION NUMBER | |
Call Number | 571.4 |
100 1# - AUTHOR NAME | |
Author | Athanasiou, Kyriacos. |
245 10 - TITLE STATEMENT | |
Title | Articular Cartilage Tissue Engineering |
250 ## - EDITION STATEMENT | |
Edition statement | 1st ed. 2010. |
300 ## - PHYSICAL DESCRIPTION | |
Number of Pages | X, 174 p. |
490 1# - SERIES STATEMENT | |
Series statement | Synthesis Lectures on Tissue Engineering, |
505 0# - FORMATTED CONTENTS NOTE | |
Remark 2 | Hyaline Articular Cartilage -- Cartilage Aging and Pathology -- In Vitro -- Bioreactors -- Future Directions. |
520 ## - SUMMARY, ETC. | |
Summary, etc | Cartilage injuries in children and adolescents are increasingly observed, with roughly 20% of knee injuries in adolescents requiring surgery. In the US alone, costs of osteoarthritis (OA) are in excess of $65 billion per year (both medical costs and lost wages). Comorbidities are common with OA and are also costly to manage. Articular cartilage's low friction and high capacity to bear load makes it critical in the movement of one bone against another, and its lack of a sustained natural healing response has necessitated a plethora of therapies. Tissue engineering is an emerging technology at the threshold of translation to clinical use. Replacement cartilage can be constructed in the laboratory to recapitulate the functional requirements of native tissues. This book outlines the biomechanical and biochemical characteristics of articular cartilage in both normal and pathological states, through development and aging. It also provides a historical perspective of past and current cartilage treatments and previous tissue engineering efforts. Methods and standards for evaluating the function of engineered tissues are discussed, and current cartilage products are presented with an analysis on the United States Food and Drug Administration regulatory pathways that products must follow to market. This book was written to serve as a reference for researchers seeking to learn about articular cartilage, for undergraduate and graduate level courses, and as a compendium of articular cartilage tissue engineering design criteria. Table of Contents: Hyaline Articular Cartilage / Cartilage Aging and Pathology / In Vitro / Bioreactors / Future Directions. |
700 1# - AUTHOR 2 | |
Author 2 | Darling, Eric M. |
700 1# - AUTHOR 2 | |
Author 2 | Hu, Jerry C. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | https://doi.org/10.1007/978-3-031-02578-5 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | eBooks |
264 #1 - | |
-- | Cham : |
-- | Springer International Publishing : |
-- | Imprint: Springer, |
-- | 2010. |
336 ## - | |
-- | text |
-- | txt |
-- | rdacontent |
337 ## - | |
-- | computer |
-- | c |
-- | rdamedia |
338 ## - | |
-- | online resource |
-- | cr |
-- | rdacarrier |
347 ## - | |
-- | text file |
-- | |
-- | rda |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Biophysics. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Materials science. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Materials. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Biomedical engineering. |
650 14 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Biophysics. |
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Materials Science. |
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Materials Engineering. |
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Biomedical Engineering and Bioengineering. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
-- | 1944-0308 |
912 ## - | |
-- | ZDB-2-SXSC |
No items available.